Cargando…
Apixaban/covid-19-vaccine-pfizer-biontech: Right superficial femoral vein thrombosis, right interlobar pulmonary embolism and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897089/ http://dx.doi.org/10.1007/s40278-022-10850-5 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Pulmonary embolism and deep venous thrombosis: case report
Publicado: (2022) -
Idiopathic pulmonary vein thrombosis treated with apixaban
por: Ngo, Dallis, et al.
Publicado: (2021) -
Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review
por: Mandernach, Molly W, et al.
Publicado: (2015) -
Portal vein thrombosis after second Pfizer/BioNTech coronavirus disease 2019 vaccine
por: Petrochko, Jameson M., et al.
Publicado: (2022) -
Isolated congenital interruption of the right interlobar pulmonary artery with unilateral interstitial lung abnormality
por: Sakabe, Mitsukuni, et al.
Publicado: (2022)